Fresh Research Confirms Enhanced Efficacy of Flavored Vaping Products in Smoking Reduction

Lotus Vaping Technologies has accomplished a groundbreaking Longitudinal Cohort Study, a first-of-its-kind examination comparing the efficacy of flavored vapor products versus tobacco-only flavored vapor products in reducing daily cigarette consumption among adult smokers.

The outcomes, while unsurprising to the vaping community, underscore the relentless advocacy for flavors for precisely this purpose. Notably, the study revealed that preferred flavors were more successful in aiding participants to quit smoking entirely (14%) compared to the commonly reported rate for FDA-approved nicotine replacement therapies (9%).

This study conclusively establishes that when adults have the liberty to select flavors that resonate with them, vaping becomes significantly more effective. According to the study results, "The reduction in cigarettes smoked per day was thus 73.9% GREATER for the flavored group than the tobacco flavor only group."

While this is the first study of its kind in the industry, it aligns with previous research emphasizing the vital role of flavors in vaping success. In 2020, researchers from the Yale School of Public Health associated vaping flavors with a 230% increase in the odds of adult smoking cessation, highlighting that adults opting for non-tobacco-flavored e-cigarettes were more likely to quit smoking.

A 2020 survey across Canada, the United Kingdom, and the United States projected that, in the event of a flavor ban, 5 out of 10 individuals would turn to the illicit market or resume smoking.

Moreover, a 2021 study examining the repercussions of a flavor ban in San Francisco discovered an alarming rise in smoking rates among teenagers for the first time in decades.

As mounting evidence unveils the adverse effects of flavor restrictions, the question arises: will the FDA Center for Tobacco Products reconsider its review standards? With Lotus Vaping Technologies' recent PMTA submission update, consumers eagerly await the FDA's response. This decision holds significant implications for the availability of these products and their potential impact on public health.

Congratulations to Lotus Vaping Technologies — we await eagerly for what unfolds next.